• 1
    Hunt R, Thompson A. Consensus Conference participants. Canadian Helicobacter pylori consensus conference. Can J Gastroenterol 1998; 12: 813.
  • 2
    Talley N, Vakil N, Ballard E, Fennerty M. Absence of benefit of eradication of Helicobacter pylori in patients with non-ulcer dyspepsia. N Engl J Med 1999; 341: 110611.DOI: 10.1056/NEJM199910073411502
  • 3
    McColl K, Murray L, El-Omar E, et al. Symptomatic benefit from eradicating Helicobacter infection in patients with non-ulcer dyspepsia. N Engl J Med 1999; 339: 186974.DOI: 10.1056/NEJM199812243392601
  • 4
    Parsonnet J. Incidence of H pylori infection. Aliment Pharmacol Ther 1995; 9: 4551.
  • 5
    Blaser M. Hypothesis. the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis 1999; 179: 152330.
  • 6
    Kang J, Tay H, Yap I, et al. Low frequency of endoscopic esophagitis in Asian patients. J Clin Gastronterol 1993; 16: 703.
  • 7
    Shimoyama T, Tominaga Y, Sakagami T, Fukugata Y. Epidemiological study for infection with H pylori in Japan compare with that in USA, Europe and Asia Pacific Area. Nippon Rinsho 1999; 57: 116.
  • 8
    Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology 1992; 102: 7606.
  • 9
    Kawaguchi H, Haruma K, Komoto K, et al. Helicobacter pylori infection is the major risk for atrophic gastritis. Am J Gastroenterol 1996; 91: 95962.
  • 10
    Yamashita Y, Fujisawa T, Kimura A, Kato H. Epidemiology of Helicobacter pylori infection in children: a serologic study of the Kyushu region in Japan. Pediatr Int 2001; 43: 47.DOI: 10.1046/j.1442-200x.2001.01337.x
  • 11
    Holtmann G, Cain C, Malfertheiner P. Gastric Helicobacter pylori infection accelerates healing of reflux oesophagitis during treatment with the proton pump inhibitor pantoprazole. Gastroenterology 1999; 117: 226.
  • 12
    Shenk B, Kuipres E, Klinkenberg-Knol E, et al. Helicobacter pylori and the efficacy of omeprazole therapy for gastroesophageal reflux disease. Am J Gastroenterol 1999; 94: 8847.DOI: 10.1016/S0002-9270(99)00037-4
    Direct Link:
  • 13
    Raghunath A, Hungin A, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastroesophageal reflux disease: a systematic review. BMJ 2003; 326: 73780.
  • 14
    Cheng EH, Bermanski P, Silversmith M, et al. Prevalence of Campylobacter pylori in esophagitis, gastritis, and duodenal disease. Arch Intern Med 1989; 149: 13735.
  • 15
    Liston R, Pitt MA, Banerjee AK. Reflux esophagitis and Helicobacter pylori infection in elderly patients. Postgrad Med J 1996; 72: 2213.
  • 16
    Vicari JJ, Peek RM, Falk GW, et al. The seroprevalance of CagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 1998; 115: 507.
  • 17
    Hackelsberger A, Schultze V, Gunther T, et al. The prevalence of Helicobacter pylori gastritis in patients with reflux esophagitis: a case control study. Eur J Gastroenterol Hepatol 1998; 10: 4858.
  • 18
    Werdmuller BF, Loffeld RJ. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig Dis Sci 1997; 42: 1035.DOI: 10.1023/A:1018841222856
  • 19
    Varanasi RV, Fantry GT, Wilson HT. Decreased prevalence of Helicobacter pylori infection in gastroesophagela reflux disease. Helicobacter 1998; 3: 18894.DOI: 10.1046/j.1523-5378.1998.08001.x
  • 20
    Kiltz U, Baier J, Schmidt WE, et al. Barrett's metaplasia and Helicobacter pylori infection. Am J Gastroenterol 1999; 94: 19856.DOI: 10.1016/S0002-9270(99)00311-1
    Direct Link:
  • 21
    Vaezi MF, Falk GW, Peek RM, et al. CagA-positive strains of Helicobacter pylori may protect against Barrett's oesophagus. Am J Gastroentrol 2000; 95: 220611.
    Direct Link:
  • 22
    Loffeld RJ, Ten Tije BJ, Arends JW. Prevalence and significance of Helicobacter pylori in patients with Barrett's esophagus. Am J Gastroenterol 1992; 87: 1598600.
  • 23
    Haruma K, Hamada H, Mihara M, et al. Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: case control study in Japan. Helicobacter 2000; 5: 249.DOI: 10.1046/j.1523-5378.2000.00003.x
  • 24
    Shirota T, Kusano M, Kawamura O, et al. Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings. J Gastroenterol 1999; 34: 5539.DOI: 10.1007/s005350050372
  • 25
    Manabe N, Yoshihara M, Sasaki A, et al. Clinical characteristics and natural history of patients with low-grade reflux esophagitis. J Gastroenterol Hepatol 2002; 17: 94954.DOI: 10.1046/j.1440-1746.2002.02783.x
  • 26
    Gastrointestinal Working Group. Helicobacter pylori and gastritis in Peruvian patients. Relationship to socioeconomic level, age and sex. Am J Gastroneterol 1990; 85: 81923.
  • 27
    Graham D, Adam E, Reddy G, et al. Seroepidemiology of Helicobacter pylori infection in India: comparison of developing and developed countries. Dia Dis Sci 1991; 36: 10848.
  • 28
    Kekki M, Samloff I, Ihamaki T, et al. Age and sex-related behaviour of astric acid secretion at the population level. Scand J Gastroenterol 1982; 17: 73743.
  • 29
    Koike T, Ohara S, Sekine H, et al. Helicobacter pylori infection inhibits reflux oesophagitis by inducing atrophic gastritis. Am J Gastroenterol 1999; 94: 346872.DOI: 10.1016/S0002-9270(99)00652-8
    Direct Link:
  • 30
    Mihara M, Harma K, Kamadad T, et al. Low prevalence of Helicobacter pylori infection in patients with reflux esophagitis. Gut 1996; 39: A94(Abstract).
  • 31
    Labenz J, Blum A, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 14427.
  • 32
    Hamada H, Haruma K, Mihara M, et al. High incidence of reflux esophagitis after eradication therapy for Helicobacter pylori: impacts of hiatal hernia and corpus gastritis. Aliment Pharmacol Ther 2000; 14: 72935.DOI: 10.1046/j.1365-2036.2000.00758.x
  • 33
    Fallone C, Barkun A, Friedman G, et al. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol 2000; 95: 91420.DOI: 10.1016/S0002-9270(00)00721-8
    Direct Link:
  • 34
    Haruma K, Mihara M, Okamaoto E, et al. Eradication of Helicobacter pylori increases gastric acidity in patients with atrophic gastritis of the corpus – evaluation of 24-h pH monitoring. Aliment Pharmacol Ther 1999; 13: 15562.DOI: 10.1046/j.1365-2036.1999.00459.x
  • 35
    Hamada H, Haruma K, Mihara M, Kamada T, Sumii K, Kajiyama G. Protective effect of ammonia against reflux esophagitis in rats. Dig Dis Sci 2001; 46: 97680.DOI: 10.1023/A:1010741424062